1/SALFORD MEDICAL PRACTICE — All Prescriptions & Medications — Page 9
Practice Code: P87004 | SALFORD, M6 5PP
Showing results 401-450 of 509
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Trospium chloride | 18 | 732 | £573 | -64.7% ▼ |
| Specialist food replacer flour type mixes (0913271) | 18 | 12.5K | £186 | -21.2% ▼ |
| Prednisolone acetate | 18 | 120 | £42 | -1.2% vs avg |
| Cocois | 18 | 1,500 | £246 | +31.1% ▲ |
| 18 | 2,100 | £2.9K | -46.7% ▼ | |
| 18 | 124 | £235 | +9.1% ▲ | |
| Sennosides | 17 | 2,895 | £56 | -45.0% ▼ |
| Safinamide | 17 | 510 | £1.1K | -15.6% ▼ |
| Vildagliptin | 17 | 840 | £297 | +17.2% ▲ |
| Sodium feredetate | 17 | 7,850 | £224 | -40.6% ▼ |
| Sodium chloride | 17 | 756 | £73 | -28.2% ▼ |
| Powder thickener - gum based (0913161) | 17 | 6,716 | £457 | -77.4% ▼ |
| Specialist food replacer rolls/baguettes (0913271) | 17 | 6,450 | £102 | -29.6% ▼ |
| Brinzolamide/brimonidine | 17 | 85 | £149 | -50.4% ▼ |
| Terbinafine hydrochloride | 17 | 630 | £112 | -54.2% ▼ |
| Ketotifen fumarate | 16 | 5,040 | £318 | +83.9% ▲ |
| Primidone | 16 | 1,672 | £2.6K | -55.0% ▼ |
| Triptorelin | 16 | 16 | £3.3K | -24.1% ▼ |
| Calcium carbonate | 16 | 928 | £83 | -75.7% ▼ |
| Gentamicin sulfate | 16 | 190 | £361 | +191.2% ▲ |
| 16 | 170 | £21 | -57.4% ▼ | |
| 16 | 2,950 | £193 | -58.0% ▼ | |
| Captopril | 15 | 784 | £243 | +3.6% ▲ |
| Valproic acid | 15 | 990 | £330 | -82.8% ▼ |
| Glucose | 15 | 1,125 | £90 | -71.2% ▼ |
| Specialist food replacer bread (0913271) | 15 | 26.1K | £243 | -65.4% ▼ |
| Dexamethasone | 15 | 105 | £105 | -74.9% ▼ |
| Carmellose sodium | 15 | 930 | £142 | -76.9% ▼ |
| Clindamycin/tretinoin | 15 | 480 | £182 | +27.8% ▲ |
| Prucalopride | 14 | 392 | £150 | -64.0% ▼ |
| Linaclotide | 14 | 392 | £500 | -23.4% ▼ |
| Zinc oxide | 14 | 421 | £49 | -32.3% ▼ |
| Co-amilozide (Amiloride hydrochloride/hydrochlorothiazide) | 14 | 392 | £181 | -14.4% ▼ |
| Verapamil hydrochloride | 14 | 392 | £103 | -84.6% ▼ |
| Brivaracetam | 14 | 966 | £2.2K | -58.8% ▼ |
| Erythromycin | 14 | 1,364 | £435 | -59.6% ▼ |
| Glipizide | 14 | 784 | £34 | +17.5% ▲ |
| Testosterone esters | 14 | 14 | £33 | -5.1% ▼ |
| Phased formulations of ethinylestradiol | 14 | 1,575 | £90 | +213.7% ▲ |
| Fesoterodine fumarate | 14 | 392 | £34 | -64.5% ▼ |
| Tocopheryl acetate | 14 | 39.2K | £29.0K | +126.6% ▲ |
| Leflunomide | 14 | 420 | £27 | -63.0% ▼ |
| Acetazolamide | 14 | 980 | £36 | -35.4% ▼ |
| 14 | 2,800 | £147 | -65.8% ▼ | |
| Sucralfate | 13 | 7,800 | £8.9K | +54.8% ▲ |
| Moxonidine | 13 | 364 | £58 | -76.6% ▼ |
| Losartan potassium with diuretic | 13 | 392 | £71 | -49.3% ▼ |
| Telmisartan with diuretic | 13 | 364 | £138 | +15.0% ▲ |
| Valsartan with diuretic | 13 | 532 | £285 | -1.9% vs avg |
| Hyoscine hydrobromide | 13 | 704 | £107 | -61.9% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.